ZA200800186B - Use of tiotropium salts in the treatment of severe persistant asthma - Google Patents

Use of tiotropium salts in the treatment of severe persistant asthma

Info

Publication number
ZA200800186B
ZA200800186B ZA200800186A ZA200800186A ZA200800186B ZA 200800186 B ZA200800186 B ZA 200800186B ZA 200800186 A ZA200800186 A ZA 200800186A ZA 200800186 A ZA200800186 A ZA 200800186A ZA 200800186 B ZA200800186 B ZA 200800186B
Authority
ZA
South Africa
Prior art keywords
treatment
tiotropium salts
asthma
severe
persistant asthma
Prior art date
Application number
ZA200800186A
Other languages
English (en)
Inventor
Engel Michael
Heinrich Stefan
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200800186(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200800186B publication Critical patent/ZA200800186B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
ZA200800186A 2005-08-06 2008-01-08 Use of tiotropium salts in the treatment of severe persistant asthma ZA200800186B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107266 2005-08-06

Publications (1)

Publication Number Publication Date
ZA200800186B true ZA200800186B (en) 2009-04-29

Family

ID=35432680

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800186A ZA200800186B (en) 2005-08-06 2008-01-08 Use of tiotropium salts in the treatment of severe persistant asthma

Country Status (16)

Country Link
US (3) US20070032516A1 (xx)
EP (1) EP1915158A1 (xx)
JP (1) JP2009504604A (xx)
KR (1) KR20080039974A (xx)
CN (1) CN101237872A (xx)
AR (1) AR055597A1 (xx)
AU (1) AU2006277968A1 (xx)
BR (1) BRPI0614394A2 (xx)
CA (1) CA2617717C (xx)
IL (1) IL189248A0 (xx)
MX (1) MX2008001506A (xx)
NZ (1) NZ566399A (xx)
RU (1) RU2422144C2 (xx)
TW (1) TWI409072B (xx)
WO (1) WO2007017438A1 (xx)
ZA (1) ZA200800186B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
PT1971332E (pt) * 2006-01-04 2011-03-18 Boehringer Ingelheim Int Utilização de sais de tiotrópio no tratamento da asma moderada persistente
KR20120109504A (ko) * 2009-11-17 2012-10-08 시플라 리미티드 흡입 용액
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5888396A (en) * 1996-12-17 1999-03-30 Perriello; Felix Anthony Bioremediation of pollutants with butane-utilizing bacteria
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
GEP20063905B (en) * 2000-10-12 2006-08-25 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
KR20060011783A (ko) * 2002-06-12 2006-02-03 에피제네시스 파마슈티칼스 아이엔씨 데하이드로에피안드로스테론 스테로이드 및항-무스카린제와 더불어 호흡기 및 폐 질환을 치료하기위한 조성물, 제제 및 키트
WO2004019985A1 (en) * 2002-08-29 2004-03-11 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
US20060269946A1 (en) * 2005-05-10 2006-11-30 Young Robert P Methods and compositions for assessment of pulmonary function and disorders
WO2006123943A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
PT1971332E (pt) 2006-01-04 2011-03-18 Boehringer Ingelheim Int Utilização de sais de tiotrópio no tratamento da asma moderada persistente

Also Published As

Publication number Publication date
RU2008108302A (ru) 2009-09-20
RU2422144C2 (ru) 2011-06-27
WO2007017438A1 (en) 2007-02-15
US20090163531A1 (en) 2009-06-25
IL189248A0 (en) 2008-08-07
NZ566399A (en) 2011-07-29
BRPI0614394A2 (pt) 2011-03-29
AR055597A1 (es) 2007-08-29
AU2006277968A1 (en) 2007-02-15
TW200744606A (en) 2007-12-16
JP2009504604A (ja) 2009-02-05
MX2008001506A (es) 2008-04-07
US20130245059A1 (en) 2013-09-19
CA2617717A1 (en) 2007-02-15
TWI409072B (zh) 2013-09-21
EP1915158A1 (en) 2008-04-30
KR20080039974A (ko) 2008-05-07
CA2617717C (en) 2014-02-11
US20070032516A1 (en) 2007-02-08
CN101237872A (zh) 2008-08-06

Similar Documents

Publication Publication Date Title
HUS1700015I1 (hu) PDGFR-alfa elleni antitest és alkalmazása tumorok kezelésénél
IL178816A0 (en) The treatment of childhood asthma
IL191317A (en) Use of cells for the preparation of a pharmaceutical preparation for complementary treatment
GB0625659D0 (en) Therapeutic compounds and their use
AP2965A (en) Therapeutic compositions and the use thereof
AP2490A (en) Therapeutic compositions and the use thereof
HK1146596A1 (en) Use of lingo-4 antagonists in the treatment of conditions involving demyelination lingo-4
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
IL199609A0 (en) Antifolate agent combinations in the treatment of cancer
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
IL188178A0 (en) Pure and stable tiotropium bromide
PL1933840T3 (pl) Zastosowanie delmopinolu w leczeniu trądziku
IL189248A0 (en) Use of tiotropium salts in the treatment of severe persistant asthma
IL192602A0 (en) Use of tiotropium salts in the treatment of moderate persistent asthma
IL199214A0 (en) New combination for use in the treatment of inflammatory disorders
GB0622479D0 (en) Novel salts and their therapeutic use
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0526292D0 (en) A composition for use in the treatment of a surface
GB2437457B (en) Game machine and self-running body for use therein
GB0516610D0 (en) Compounds for use in therapy
GB0614538D0 (en) Therapeutic Compounds And Their Use
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis
HK1107046A1 (en) Game machine and self-running body for use therein